Blog
How Long Do Semaglutide Side Effects Last and When They Ease
How Long Do Semaglutide Side Effects Last, by the Trial Data
How long do semaglutide side effects last is usually asked by someone feeling unwell right now who wants a number rather than reassurance. There are numbers, from pooled data across the STEP trials published by Wharton and colleagues in Diabetes, Obesity and Metabolism in 2022.
In that analysis a nausea episode lasted a median of 8 days, diarrhea 3 days and vomiting 2 days. Constipation was the outlier at a median of 47 days. Semaglutide side effects commonly return when a dose changes, which is the part most pages leave out.
How long each of the semaglutide side effects lasted
| Side effect | Median episode duration | How it behaves |
| Vomiting | 2 days | Short and self limiting in most reported cases |
| Diarrhea | 3 days | Short. Fluid loss is the reason to contact support if it persists |
| Nausea | 8 days | The most commonly reported effect and the one most likely to recur when a dose changes |
| Constipation | 47 days | The outlier. It does not follow the same pattern as the others |
Source: Wharton and colleagues, Diabetes, Obesity and Metabolism, 2022, pooled STEP 1 to 3 data.
Read those numbers correctly
Two things need saying before you use that table of semaglutide side effects, and neither appears on the pages that quote figures like these.
First, these are median durations of a single episode, not how long you will feel unwell in total. Someone who has felt nauseated on and off for three weeks has probably had several episodes rather than one long one. The 8 day figure is not a promise that nausea ends on day 8, and roughly half of episodes ran longer than the median by definition.
Second, this data comes from trials of a branded, FDA-approved product. AHC prescribes compounded semaglutide, which is not FDA-approved and has not been reviewed by the FDA for safety, efficacy or quality. It was not studied in these trials. The figures describe what was observed in that trial population and AHC does not project them onto its own product or onto you. Results vary by individual and depend on adherence, clinical guidance, and lifestyle factors.
With those two caveats attached, the table is still more useful than the vague few weeks that most pages offer when asked how long do semaglutide side effects last.
Why you often feel worst one to three days after the injection
Semaglutide does not reach its peak in the bloodstream on injection day. FDA prescribing information for the branded product puts peak concentration at approximately one to three days after a subcutaneous injection.
That explains a pattern people find confusing. You take the shot, feel fine, and feel worse two days later. Nothing has gone wrong. That is the medication reaching its peak.
It also explains why skipping a day does not reduce semaglutide side effects. The elimination half life is roughly one week, so the medication does not clear quickly, and a single missed day changes very little. If your injection day consistently lands badly, that is worth raising with an AHC provider rather than solving by moving doses around yourself.
Why symptoms return when your dose changes
This is the part that answers what most people are really asking, and it appears on almost no page ranking for the term.
GLP-1 treatment follows a titration schedule, and that schedule is what shapes semaglutide side effects over time. The dose starts low and increases step by step so the body can adjust, and early doses are intentionally mild. FDA labeling for the branded product is explicit that gastrointestinal reactions were most frequently reported during dosage escalation.
Put those together and the pattern becomes predictable rather than random. Your body adapts to each dose, which is why the same dose gets easier over a few weeks and why a step up can feel like starting again. If a dose increase feels like a setback after a good stretch, the timing is not a coincidence.
AHC does not publish dose schedules, dosing charts or unit conversions on public pages. Your dosage instructions come to you individually by email after an AHC provider approves your order, and adjustments depend on your response, your side effects and your time at the current dose. A provider reviews every one. If you are not tolerating a dose, contact AHC support. The medical officer reviews the request, and delaying a step up is a clinical decision rather than something to arrange yourself.
Which semaglutide side effects fade and which do not
Treating all semaglutide side effects as one category is why people get poor guidance. The pooled data splits them into two groups that behave differently.
Nausea, vomiting and diarrhea are episodic, with median durations from 2 to 8 days. In the pooled analysis the overwhelming majority of gastrointestinal events were non-serious and mild to moderate, and the authors described them as transient and occurring most often during or shortly after dose escalation.
Constipation behaves differently. A median episode duration of 47 days is roughly six times longer than nausea, and the pattern in the data does not suggest it resolves by adaptation the way the others do. The reason is mechanical rather than about tolerance, since this class of medication slows how quickly the stomach empties for as long as you are dosing.
That is a reason to raise persistent constipation with a provider rather than to wait it out. AHC does not publish advice on managing digestive symptoms, so what to do about it is a clinical conversation and not something to take from an article. The AHC patient FAQs set out how to reach the support team.
When new semaglutide side effects stop appearing
The pooled analysis tracked when participants experienced their first gastrointestinal side effect. The cumulative incidence plateaued after week 20.
In practical terms, in that trial population, people past that point who had not had a particular effect were less likely to develop it later at the same dose. It does not mean existing symptoms disappear at a fixed point, it does not apply if a dose changes again, and it is a trial observation rather than a schedule for any individual.
This is also the most commonly misread figure in writing about semaglutide side effects. A plateau in first occurrences is not the same as an end date, and any page presenting it as one has misunderstood the analysis.
How long semaglutide stays in your system
FDA prescribing information for the branded product states an elimination half life of approximately seven days, and that semaglutide is present in circulation for around five to seven weeks after the last dose.
That figure explains several things at once. It is why blood levels take several weeks to reach steady state, why a single missed day changes little, and why anyone planning a pregnancy is advised to discuss stopping well in advance with a provider.
What the evidence does not settle
Anyone asking how long do semaglutide side effects last after stopping deserves an honest answer, and the honest answer is that the data does not exist.
The STEP 1 trial extension followed participants for a year after they stopped. It stated directly that no systematic collection of adverse events was performed in the extension. There is no trial derived timeline for how quickly symptoms resolve after stopping.
What is known is pharmacological. The medication clears from circulation over roughly five to seven weeks, so effects driven by its presence would be expected to ease across that window. Any page giving you a confident number for this is not citing data, because there is none to cite.
Stopping is a decision for a provider rather than one to make in response to a bad week. Contact AHC support and the medical officer reviews the request. If tiredness is the effect bothering you most, AHC covers that separately in its post on semaglutide side effects and fatigue.
| Not started yet? Start your medical intake and an AHC provider will review your history. |
Symptoms that need attention rather than patience
Everything above describes expected semaglutide side effects. Some symptoms are not part of that picture. FDA labeling for the branded product lists acute and necrotizing pancreatitis, and ileus, intestinal obstruction and severe constipation including fecal impaction, under postmarketing experience.
- Severe, persistent abdominal pain, especially pain radiating to the back, with or without vomiting.
- Constipation that becomes an inability to pass stool or gas, with abdominal swelling or vomiting. This is not the ordinary constipation described above.
- Pain in the upper right abdomen, fever, or yellowing of the skin or eyes.
- Vomiting or diarrhea severe enough that you cannot keep fluids down.
- Signs of low blood sugar if you also take insulin or a sulfonylurea.
- Any swelling of the face, lips or throat, or difficulty breathing.
- Any lump or swelling in the neck, hoarseness, difficulty swallowing or persistent shortness of breath. Semaglutide carries a boxed warning regarding thyroid C-cell tumors observed in rodents, and is contraindicated in people with a personal or family history of medullary thyroid carcinoma or with Multiple Endocrine Neoplasia syndrome type 2.
If any of these apply, contact AHC support or seek medical care. Do not wait for a scheduled check in, and seeking care comes first. This page does not offer management advice for any of them, because that is a clinical judgment and not an article one.
What AHC publishes and what it does not
Worth stating plainly, because it shapes what you should expect from this page.
AHC publishes what the trial literature reports about semaglutide side effects, their duration, timing and pharmacology, with its sources named and its limits attached. If you are new to the category, start with what a GLP-1 medication is. AHC does not publish dosing charts, titration schedules, unit conversions or symptom management routines on public pages.
Dosage instructions reach you individually by email after an AHC provider approves your order. Dose changes go through AHC support, where the medical officer reviews the request. Never lower, skip, double or change a dose on your own in response to how you feel.
Contact AHC support through live chat on the website or at [email protected].
| The short version: how long do semaglutide side effects last depends on which effect, with median episodes of 2 to 8 days for vomiting, diarrhea and nausea and 47 days for constipation in pooled trial data, and symptoms commonly return when a dose changes. |
Frequently asked questions
How long do semaglutide side effects last in total?
Individual episodes had median durations of 2 to 8 days for vomiting, diarrhea and nausea, and 47 days for constipation, in pooled trial data. Because symptoms tend to recur when a dose changes, the period during which they occur at all commonly spans the titration phase.
When do semaglutide side effects start?
Usually within the first days of the first dose, with symptoms often clustering one to three days after an injection, because that is when the medication peaks in the blood.
Do semaglutide side effects come back when the dose increases?
Commonly, yes. FDA labeling for the branded product states gastrointestinal reactions were most frequently reported during dosage escalation. AHC does not publish the schedule itself, since dosage instructions are sent to each customer individually.
How long does nausea last on semaglutide?
A median of 8 days per episode in pooled trial data. That is a median from a trial population rather than a prediction for you, and roughly half of episodes ran longer.
How long does constipation last on semaglutide?
A median of 47 days per episode, considerably longer than the other gastrointestinal effects, and it does not appear to resolve by adaptation the way the others do. Raise it with a provider rather than waiting it out.
Why do semaglutide side effects last longer than with other medications?
Because of the half life. The elimination half life is around seven days, so the medication remains in circulation for roughly five to seven weeks after the last dose. Most medications clear far faster.
Are semaglutide side effects dangerous?
Most semaglutide side effects in the pooled trial data were non-serious and mild to moderate. Serious complications including pancreatitis and intestinal obstruction are listed in the labeling and need urgent attention. See the section on symptoms that need attention.
Should I stop taking semaglutide because of side effects?
That is a decision for a provider. Contact AHC support and the medical officer reviews the request. Never stop, skip or change a dose on your own.
How long do semaglutide side effects last after stopping?
There is no trial data on this. The STEP 1 extension explicitly did not collect adverse events after withdrawal. The medication clears from circulation over roughly five to seven weeks, which is the only figure that can be stated with confidence.
Do semaglutide side effects mean the medication is working?
No. Side effects and weight change are not linked in a way that lets you read one from the other. AHC makes no outcome claims in either direction.
Does everyone get semaglutide side effects?
No. Reported rates in the trials were high but far from universal, and everyone responds at their own pace. Results vary by individual and depend on adherence, clinical guidance, and lifestyle factors.
Does this trial data apply to compounded semaglutide?
It was not generated on compounded formulations. Compounded semaglutide is not FDA-approved and has not been reviewed by the FDA for safety, efficacy or quality. The figures describe what was observed in trials of a branded product, and AHC does not project them onto its own product.
Can I ask about my own semaglutide side effects in the $29.99 consultation?
Yes. Bring your full medication and supplement list. For anything severe, contact AHC support or seek medical care first.
| Have a question about your own situation? Speak with a licensed provider for $29.99. |
Medical Disclaimer
Compounded medications are prepared by state-licensed compounding pharmacies. They are not FDA-approved and have not been reviewed by the FDA for safety, efficacy, or quality.
Results vary by individual and depend on adherence, clinical guidance, and lifestyle factors.
This content is for informational purposes only and is not medical advice. Clinical services are provided by independently contracted, U.S.-licensed clinicians. Speak with a licensed provider about your individual situation.
Contact AHC support through live chat on the website or at [email protected].